Back
Neurogene Quote, Financials, Valuation and Earnings
Sponsored
NGNE
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
5
NGNE
Neurogene
Last Price:
39.61
Seasonality Move:
50.43%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeNeurogene Price Quote
$39.61
+0.07 (+-0.98%)
(Updated: November 14, 2024 at 5:27 AM ET)
Neurogene Key Stats
Sell
5
Neurogene (NGNE)
is a Sell
Day range:
$39.08 - $41.33
52-week range:
$12.49 - $74.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.35%
Volume:
588.4K
Avg. volume:
250.8K
1-year change:
194.2%
Market cap:
$519.7M
Revenue:
$0
EPS:
$-20.01
How Much Does Neurogene Make?
Data Unavailable
Is Neurogene Growing As A Company?
Data Unavailable
Neurogene Stock Price Performance
What Is Neurogene 52-Week High & Low?
Neurogene Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Neurogene?
Is Neurogene Cash Flow Positive?
Neurogene Return On Invested Capital
Data Unavailable
Neurogene Earnings Date & Stock Price
-
What Is Neurogene's Stock Price Today?
A single share of NGNE can be purchased today for 39.54 -
What Is Neurogene’s Stock Symbol?
Neurogene trades on the nasdaq under the ticker symbol: NGNE -
When Is Neurogene’s Next Earnings Date?
The next quarterly earnings date for Neurogene is scheduled on November 29, 2024 -
When Is NGNE's next ex-dividend date?
Neurogene's next ex-dividend date is November 14, 2024 -
How To Buy Neurogene Stock?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Neurogene Competitors
Neurogene Dividend Yield
-
What Is NGNE Dividend Yield?
Neurogene’s dividend yield currently is 0% -
What Is Neurogene’s Payout Ratio?
Neurogene’s payout ratio is 0% -
When Did Neurogene Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Neurogene’s Dividend Per Share?
Neurogene pays a dividend of $0.00 per share
Neurogene Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 57.20 |
Upside from Last Price: | 44.66% |